NMN Supplementation Shows Positive Impact on Blood Pressure Says Study

Declining NAD+ levels, a typical outcome of aging, have been linked to age-related cardiovascular health issues in the past. However, no clinical human trials have reported on the intricacies of the relationship between NAD+ and elevated blood pressure until now.

Researchers in this exciting study went more in-depth than any other had before. They demonstrated that supplementing with NMN, the preeminent NAD+ precursor, significantly reduced blood pressure in people with hypertension.